136 related articles for article (PubMed ID: 38102745)
1. Comorbidities associated with symptoms of subjective cognitive decline in individuals aged 45-64.
Monahan Z; Heath J; Santos AD; Ford A; Hartwell M
J Osteopath Med; 2024 Jun; 124(6):277-283. PubMed ID: 38102745
[TBL] [Abstract][Full Text] [Related]
2. Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway.
Strand BH; Knapskog AB; Persson K; Edwin TH; Amland R; Mjørud M; Bjertness E; Engedal K; Selbæk G
PLoS One; 2018; 13(9):e0204436. PubMed ID: 30240425
[TBL] [Abstract][Full Text] [Related]
3. Subjective Cognitive Decline Among Adults Aged ≥45 Years - United States, 2015-2016.
Taylor CA; Bouldin ED; McGuire LC
MMWR Morb Mortal Wkly Rep; 2018 Jul; 67(27):753-757. PubMed ID: 30001562
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.
Sheikh F; Ismail Z; Mortby ME; Barber P; Cieslak A; Fischer K; Granger R; Hogan DB; Mackie A; Maxwell CJ; Menon B; Mueller P; Patry D; Pearson D; Quickfall J; Sajobi T; Tse E; Wang M; Smith EE;
Int Psychogeriatr; 2018 Feb; 30(2):233-244. PubMed ID: 28879833
[TBL] [Abstract][Full Text] [Related]
5. Relation Between Smoking Status and Subjective Cognitive Decline in Middle Age and Older Adults: A Cross-Sectional Analysis of 2019 Behavioral Risk Factor Surveillance System Data.
Rajczyk JI; Ferketich A; Wing JJ
J Alzheimers Dis; 2023; 91(1):215-223. PubMed ID: 36373317
[TBL] [Abstract][Full Text] [Related]
6. Identifying latent comorbidity patterns in adults with perceived cognitive impairment: Network findings from the behavioral risk factor surveillance system.
Ramos-Vera C; Saintila J; O'Diana AG; Calizaya-Milla YE
Front Public Health; 2022; 10():981944. PubMed ID: 36203679
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
[TBL] [Abstract][Full Text] [Related]
8. A Fay-Herriot Model for Estimating Subjective Cognitive Decline among Military Veterans.
McDaniel JT; McDermott RJ; Schneider T
J Prev Alzheimers Dis; 2021; 8(4):457-461. PubMed ID: 34585220
[TBL] [Abstract][Full Text] [Related]
9. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
[TBL] [Abstract][Full Text] [Related]
10. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
[TBL] [Abstract][Full Text] [Related]
11. Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline.
Ismail Z; McGirr A; Gill S; Hu S; Forkert ND; Smith EE
J Alzheimers Dis; 2021; 80(1):459-469. PubMed ID: 33554909
[TBL] [Abstract][Full Text] [Related]
12. Racial and ethnic differences in post-stroke subjective cognitive decline exist.
Burns SP; Mueller M; Magwood G; White BM; Lackland D; Ellis C
Disabil Health J; 2019 Jan; 12(1):87-92. PubMed ID: 30115583
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F;
Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834
[TBL] [Abstract][Full Text] [Related]
14. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
[TBL] [Abstract][Full Text] [Related]
15. Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Stogmann E; Moser D; Klug S; Gleiss A; Auff E; Dal-Bianco P; Pusswald G; Lehrner J
J Alzheimers Dis; 2016; 49(4):1043-50. PubMed ID: 26577522
[TBL] [Abstract][Full Text] [Related]
16. A latent class analysis of cognitive decline in US adults, BRFSS 2015-2020.
Snead R; Dumenci L; Jones RM
BMC Public Health; 2022 Aug; 22(1):1560. PubMed ID: 35974367
[TBL] [Abstract][Full Text] [Related]
17. Racial and Ethnic Differences in Subjective Cognitive Decline - United States, 2015-2020.
Wooten KG; McGuire LC; Olivari BS; Jackson EMJ; Croft JB
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(10):249-255. PubMed ID: 36893045
[TBL] [Abstract][Full Text] [Related]
18. Racial and ethnic disparities in subjective cognitive decline: a closer look, United States, 2015-2018.
Gupta S
BMC Public Health; 2021 Jun; 21(1):1173. PubMed ID: 34162356
[TBL] [Abstract][Full Text] [Related]
19. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
Fernández-Blázquez MA; Ávila-Villanueva M; Maestú F; Medina M
J Alzheimers Dis; 2016 Mar; 52(1):271-81. PubMed ID: 27060949
[TBL] [Abstract][Full Text] [Related]
20. Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.
Johnson LA; Gamboa A; Vintimilla R; Cheatwood AJ; Grant A; Trivedi A; Edwards M; Hall JR; O'Bryant SE
J Alzheimers Dis; 2015; 47(1):129-36. PubMed ID: 26402761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
